Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
284 participants
OBSERVATIONAL
2018-11-20
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581
Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS
NCT02470351
Thinking and Memory Problems in People With HIV
NCT01875588
HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs
NCT00001103
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
NCT01665846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persons Living with HIV (PLWH)
Persons 20-80 years old with a documented HIV infection for at least 1 year, who are on a stable cART medication regimen for at least 1 year, and have an undetectable plasma HIV RNA (\<50 copies/ml).
Imaging
3T Prisma MRI
Serum Laboratory Tests
Blood (plasma and cellular) will be collected.
Lumbar Puncture
CSF will be collected
HIV- Controls
Persons 20-80 years old with confirmed HIV- status matched to PLWH cohort with similar age, sex, education, and race.
Imaging
3T Prisma MRI
Serum Laboratory Tests
Blood (plasma and cellular) will be collected.
Lumbar Puncture
CSF will be collected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imaging
3T Prisma MRI
Serum Laboratory Tests
Blood (plasma and cellular) will be collected.
Lumbar Puncture
CSF will be collected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* documented HIV infection for at least 1 year or confirmed HIV - status
* PLWH must be on stable cART regimen for at least 12 months with undetectable plasma HIV RNA (less than 50 copies per mL)
* at least 9 years of education
* able to provide informed consent
* if female, a negative pregnancy test and not breast feeding
* able to undergo an MRI scan
Exclusion Criteria
* active uncontrolled Axis I psychiatric disorder according to the DSM 5
* current or history of substance use disorder (including, but not limited to amphetamines, cocaine, alcohol, opiates, and barbiturates)
* prescribed blood thinners
* allergic to lidocaine or similar anesthetic
* history of any bleeding disorder
* contraindication to MRI scanning (e.g. claustrophobia, pacemaker, etc.)
* pregnant or breastfeeding
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of Missouri, St. Louis
OTHER
Temple University
OTHER
University of California, San Diego
OTHER
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beau M Ances, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201805047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.